Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

88.46
BATS BZX Real-Time Price
As of 2:19pm ET
 +1.91 / +2.21%
Today’s Change
77.92
Today|||52-Week Range
120.37
-12.58%
Year-to-Date
Market's Lower, But These 3 Stocks Aren't
1:23pm / TheStreet.com - Paid Partner Content
10 Low PE Stocks for the Enterprising Investor
Jul 20 / GuruFocus News - Paid Partner Content
Is Timeframe on Your Side?
12:23pm / TheStreet.com - Paid Partner Content
Will Honeywell (HON) Pull a Surprise this Earnings Season?
Jul 20 / Zacks.com - Paid Partner Content
Is Time Frame on Your Side?
12:06pm / TheStreet.com - Paid Partner Content
Zacks.com featured highlights: Altria Group, Priceline Group, Zoetis, Gilead Sciences...
Jul 20 / Zacks.com - Paid Partner Content
I'm Bullish on Biotechs
11:58am / TheStreet.com - Paid Partner Content
Why Gilead Sciences (GILD) Might Surprise This Earnings Season
Jul 20 / Zacks.com - Paid Partner Content
Busiest Week for Q2 Earnings Now Underway
10:30am / Zacks.com - Paid Partner Content
Can Stryker (SYK) Pull an Earnings Surprise this Season?
Jul 20 / Zacks.com - Paid Partner Content
Morning Movers: YHOO, VZ, DHR, GILD
8:21am / TheStreet.com - Paid Partner Content
Earnings Estimates for These 3 Biotech Giants Should Be Heading Lower -- Here's Why
Jul 19 / MotleyFool.com - Paid Partner Content
Stocks: 5 things to know before the open
5:08am / CNNMoney.com
5 Best Stocks For Value Investors This Week
Jul 19 / GuruFocus News - Paid Partner Content
5 Reasons Biotech Stocks Are Smart Investments
Jul 24 / MotleyFool.com - Paid Partner Content
5 Stocks with High ROE to Buy as Earnings Bells Chime
Jul 19 / Zacks.com - Paid Partner Content
3 Stocks That Turned $10,000 Into $1 Million
Jul 24 / MotleyFool.com - Paid Partner Content
4 Top Stocks on Sale This Summer
Jul 19 / MotleyFool.com - Paid Partner Content
I Just Bought These 4 Fast-Growing Biotech Stocks
Jul 23 / MotleyFool.com - Paid Partner Content
3 Biotech Stocks to Buy and Hold
Jul 19 / MotleyFool.com - Paid Partner Content
These 4 Stocks Could See Negative Catalysts From Earnings -- but What Do the Charts S...
Jul 22 / TheStreet.com - Paid Partner Content
Roche's Gazyva Fails in Phase III B-cell Lymphoma Study
Jul 18 / Zacks.com - Paid Partner Content
Gilead Sciences (GILD) Stock Drops Ahead of Q2 Earnings Report
Jul 22 / TheStreet.com - Paid Partner Content
Don't Give Up On Gilead Sciences
Jul 18 / TheStreet.com - Paid Partner Content
Medical Stocks Reporting Early Next Week: GILD, LLY & More
Jul 22 / Zacks.com - Paid Partner Content
Abbott Labs (ABT) Q2 Earnings: Will the Stock Surprise?
Jul 18 / Zacks.com - Paid Partner Content
Can GoPro (GPRO) Spring a Surprise this Earnings Season?
Jul 22 / Zacks.com - Paid Partner Content
Is This Gilead Sciences' Most Underappreciated Drug Candidate?
Jul 18 / MotleyFool.com - Paid Partner Content
Gilead (GILD) Stock Likely to Beat This Earnings Season
Jul 21 / Zacks.com - Paid Partner Content
TE Connectivity (TEL) Q3 Earnings: What's in the Cards?
Jul 18 / Zacks.com - Paid Partner Content
What's in Store for TransUnion (TRU) This Earnings Season?
Jul 21 / Zacks.com - Paid Partner Content
Novartis (NVS) Likely to Beat Q2 Earnings: Stock to Gain?
Jul 15 / Zacks.com - Paid Partner Content
3 Healthcare ETFs to Buy as JNJ Beats Q2 Earnings
Jul 21 / Zacks.com - Paid Partner Content
Will UnitedHealth (UNH) Continue to Beat on Earnings in Q2?
Jul 15 / Zacks.com - Paid Partner Content
4 Small-Cap Biotechs With Big Stories to Tell
Jul 21 / TheStreet.com - Paid Partner Content
Gilead's HCV Drug Epclusa Gets Regulatory Nod in Canada
Jul 15 / Zacks.com - Paid Partner Content
3 Enormously Important Things You Won't See in Gilead Sciences' Q2 Results
Jul 21 / MotleyFool.com - Paid Partner Content
Biogen (BIIB) Q2 Earnings: Will the Stock Disappoint?
Jul 15 / Zacks.com - Paid Partner Content
Biogen (BIIB) Stock Up on Q2 Earnings Beat, Raised Outlook
Jul 21 / Zacks.com - Paid Partner Content
J&J (JNJ) May Beat Q2 Earnings: Will the Stock Gain?
Jul 15 / Zacks.com - Paid Partner Content
Express Scripts (ESRX) Q2 Earnings: Stock to Disappoint?
Jul 21 / Zacks.com - Paid Partner Content
3 Dividend Aristocrats to Avoid
Jul 14 / MotleyFool.com - Paid Partner Content
Eli Lilly (LLY) May Beat Q2 Earnings: Will the Stock Gain?
Jul 21 / Zacks.com - Paid Partner Content
How Much Do Stock Prices Matter in Biotech?
Jul 14 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Celgene in Immuno-Oncology Deal, Zafgen Drops Lead Drug
Jul 20 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Juno, Amgen, AbbVie, Gilead and CytRx
Jul 14 / Zacks.com - Paid Partner Content
Abbott (ABT) Beats on Earnings & Sales in Q2, Maintains View
Jul 20 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Juno In and Out of Clinical Hold, Amgen Biosimilar Gets Panel ...
Jul 13 / Zacks.com - Paid Partner Content
Better Buy: Gilead Sciences Inc. vs. Amgen Inc.
Jul 20 / MotleyFool.com - Paid Partner Content
Why Investors Are Underestimating Gilead Sciences
Jul 13 / MotleyFool.com - Paid Partner Content